At the time of writing, Fresenius Medical Care AG ADR [FMS] stock is trading at $22.33, up 3.00%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The FMS shares have gain 4.39% over the last week, with a monthly amount drifted -5.02%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Fresenius Medical Care AG ADR [NYSE: FMS] stock has seen the most recent analyst activity on January 20, 2026, when Goldman downgraded its rating to a Neutral. Previously, BofA Securities downgraded its rating to Underperform on October 15, 2025. On September 02, 2025, downgrade downgraded it’s rating to Sell. BofA Securities upgraded its rating to a Neutral. Berenberg initiated its recommendation with a Buy and recommended $25.60 as its price target on November 06, 2024. Morgan Stanley downgraded its rating to Underweight for this stock on January 08, 2024. In a note dated November 24, 2023, HSBC Securities upgraded a Hold rating on this stock.
For the past year, the stock price of Fresenius Medical Care AG ADR fluctuated between $20.94 and $30.46. Currently, Wall Street analysts expect the stock to reach $28 within the next 12 months. Fresenius Medical Care AG ADR [NYSE: FMS] shares were valued at $22.33 at the most recent close of the market. An investor can expect a potential return of 25.39% based on the average FMS price forecast.
Analyzing the FMS fundamentals
According to Fresenius Medical Care AG ADR [NYSE:FMS], the company’s sales were 21.71B for trailing twelve months, which represents an 9.16% jump. Gross Profit Margin for this corporation currently stands at 0.25% with Operating Profit Margin at 0.08%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.04%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.05 and Total Capital is 0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.81.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Fresenius Medical Care AG ADR [NYSE:FMS] has a current ratio of 1.36. In addition, the Quick Ratio stands at 1.00 and the Cash Ratio stands at 0.22. Considering the valuation of this stock, the price to sales ratio is 0.60, the price to book ratio is 0.85 and price to earnings (TTM) ratio is 16.20.
